1,296 results on '"Gurm, Hitinder S."'
Search Results
152. The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention
153. Institutional Red Blood Cell Transfusion Rates Are Correlated Following Endovascular and Surgical Cardiovascular Procedures: Evidence That Local Culture Influences Transfusion Decisions
154. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting
155. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors
156. Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCI
157. Differences in the outcome of patients undergoing percutaneous coronary interventions at teaching versus non-teaching hospitals
158. The Ongoing Importance of Smoking as a Powerful Risk Factor for ST-Segment Elevation Myocardial Infarction in Young Patients
159. Predicting complications of percutaneous coronary intervention using a novel support vector method
160. Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention
161. Channelling regional registries for optimization of cardiac care: lessons from around the world
162. Preprocedural white blood cell count and death after percutaneous coronary intervention
163. Resistance to Antiplatelet Drugs
164. The changing definition of contrast-induced nephropathy and its clinical implications: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
165. Cardiac Rehabilitation Use After Percutaneous Coronary Intervention
166. Physician Specialty and Carotid Stenting Among Elderly Medicare Beneficiaries in the United States
167. Operator Experience and Carotid Stenting Outcomes in Medicare Beneficiaries
168. In a pinch
169. Trends and outcomes of non-primary PCI at sites without cardiac surgery on-site: The early Michigan experience
170. Renal Disease and Coronary, Peripheral and Structural Interventions
171. Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program
172. Surviving the “After-Shock”
173. A Complementary Approach for Preventing Contrast-Induced Acute Kidney Injury
174. Preprocedural statin use in patients undergoing percutaneous coronary intervention
175. Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting
176. Trends in Door-to-Balloon Time and Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
177. Fragmented QRS Complex Has Poor Sensitivity in Detecting Myocardial Scar
178. Reply
179. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials
180. Current Approach to the Diagnosis and Treatment of Femoral-Popliteal Arterial Disease. A Systematic Review
181. Chronic Obstructive Pulmonary Disease as a Predictor of Mortality in Patients Undergoing Percutaneous Coronary Intervention
182. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center
183. Does Gadolinium-Based Angiography Protect Against Contrast-Induced Nephropathy?: A Systematic Review of The Literature
184. Risk of Death Or Emergency Cardiac Surgery in Contemporary Elective Percutaneous Coronary Interventions; Implications for Percutaneous Coronary Interventions Without Onsite Bypass Surgery: 2805-8
185. Predictors and Implications of Q-Waves in ST-Elevation Acute Coronary Syndromes
186. Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis
187. The Human Bovine Arch—A Common Misnomer
188. Temporal Trends, Safety, and Efficacy of Bivalirudin in Elective Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
189. Impact of Diabetes Mellitus on Outcome of Patients Undergoing Carotid Artery Stenting: Insights From a Single Center Registry
190. Renal failure after percutaneous coronary intervention is associated with high mortality
191. The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
192. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: Lessons from the GUSTO V trial
193. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions
194. Guarding the Kidneys: Re-Examining the Role of Prophylactic Hydration in Contemporary Interventional Practice.
195. Relation of Cyclooxygenase Isoenzyme Expression and Coronary Artery Remodeling
196. Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2)
197. IN-HOSPITAL DEATH AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A ROOT-CAUSE ANALYSIS
198. Relationship Between Troponin on Presentation and In‐Hospital Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
199. Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention
200. Upstream Impact of Public Reporting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.